EBITDA Multiples by Industry: South Korea 2026

South Korean mid-market businesses sell for 3–15x EBITDA in 2026, with healthcare and biopharma services at the top of the range and construction at the lower end. South Korea’s structural M&A catalysts — the Corporate Value-Up Program driving chaebol carve-outs, record inbound private equity deployment, and growing global demand for Korean healthcare and consumer capabilities — have created one of Asia Pacific’s most dynamic deal markets for well-prepared sellers. Lyndon Advisory advises South Korea sell-side transactions on a 2% success-fee-only basis, capped at US$300,000.

Sector	EBITDA Multiple (2026)
Healthcare & biopharma (pharma services, CRO/CMO, clinics, diagnostics)	8–15x
Technology (SaaS, enterprise software, IT services)	7–13x
Consumer brands (K-beauty, K-food, cultural IP)	6–10x
Financial services (fintech, insurance, wealth management)	5–9x
Education technology (corporate training, professional certification)	4–8x
Professional services (consulting, HR outsourcing, accounting)	4–7x
Industrial manufacturing (precision, automotive components, electronics)	4–7x
Logistics and supply chain	4–6x
Construction and engineering services	3–5x

₩5B–₩300B enterprise value, competitive process, Q1–Q2 2026. Chaebol carve-outs and succession-driven deals typically price at the midpoint of each range.

“South Korea is one of Asia Pacific’s most underestimated M&A markets for mid-market sellers. Korean business owners — especially those outside the chaebol ecosystem — routinely sell to a single domestic buyer without testing the international market. A structured process that simultaneously engages Korean PE sponsors, Japanese industrials, European healthcare strategics, and US technology buyers almost always produces a meaningfully better outcome for the seller.”

— Daniel Bae, Founder & CEO, Lyndon Advisory ($30B+ transaction experience)

For the broader valuation framework behind these benchmarks, see Lyndon’s M&A valuation guide. For a regional comparison, see EBITDA multiples for Japan 2026, EBITDA multiples for Singapore 2026, EBITDA multiples for Hong Kong 2026, EBITDA multiples for Malaysia 2026, and EBITDA multiples for Thailand 2026.

How EBITDA Multiples Work in South Korea

An EBITDA multiple expresses how many years of normalised EBITDA a buyer is willing to pay to acquire a business. A business with ₩10B normalised EBITDA selling at 8x achieves an ₩80B enterprise value.

South Korea multiples reflect several structural factors specific to the market:

• Sector — healthcare and biopharma consistently command the highest multiples; construction and logistics the lowest
• Export potential — businesses with proven APAC or global revenue diversification trade at a significant premium over purely domestic plays
• Management independence — a business that operates without the founder is critical for PE sponsors and foreign strategic buyers; succession deals with thin management benches trade at a discount
• Chaebol versus independent origin — carve-out assets divested by chaebols under Value-Up Program pressure often carry embedded operational inefficiency that buyers can unlock; independent mid-market companies with clean governance typically price at or above the sector midpoint
• Cross-border buyer access — businesses with IP, manufacturing processes, or clinical capabilities relevant to Japanese, European, or US strategic buyers achieve higher competitive tension
• Governance quality — Korean mid-market companies that have invested in IFRS or K-GAAP financial quality, independent board oversight, and clean related-party transactions command a clear premium over those with opaque structures

South Korea’s most significant tax consideration for sellers: approximately 25% capital gains tax on share sale gains for individuals (combining national income tax and local income tax surcharge). Pre-sale reorganisation through Singapore, the Netherlands, or another Korean tax-treaty jurisdiction is a common mitigation strategy. A Korea-specific tax opinion before entering any process is essential; treaty qualification, holding structure, and transaction timing all affect the final tax cost.

South Korea EBITDA Multiples by Sector (2026)

Healthcare and Biopharma

South Korea’s healthcare sector spans world-class biopharma and biosimilar manufacturers (Samsung Biologics, Celltrion, Hanmi Pharmaceutical), contract research and manufacturing organisations (CRO/CMO), specialist clinics, dental chains, diagnostics, and medical device producers. Korean pharmaceutical manufacturing capabilities have genuine global demand — US, European, and Japanese pharmaceutical companies are active acquirers of Korean CMO capacity and biosimilar development platforms.

According to PwC’s 2026 mid-year M&A outlook, healthcare remains one of the strongest global sectors for PE deployment. In Korea, healthcare businesses with scalable protocols, export-ready regulatory documentation, and management-independent operations achieve 10–15x EBITDA in competitive processes. Regional clinic networks and specialist practices with strong recurring revenues achieve 8–12x. Korean healthcare is one of the few sectors where domestic multiples are structurally competitive with Singapore, driven by genuine global buyer appetite.

Key buyers: Bain Capital Asia, MBK Partners, global healthcare PE funds, US pharmaceutical corporates, European CRO/CMO strategic acquirers, and Japanese healthcare consolidators.

Technology and Software

Korea’s technology sector spans large IT service companies (SI businesses), growing SaaS platforms, fintech infrastructure providers, and cybersecurity specialists. Enterprise software businesses with high recurring contract revenue, government or financial-sector customer bases, and APAC expansion potential achieve 9–13x EBITDA in competitive processes. IT services and managed services businesses with defensible contract positions achieve 7–10x.

According to Bain’s Asia-Pacific Private Equity Report 2026, technology remains the most active PE investment sector in Asia Pacific. Korean AI and SaaS businesses with demonstrated recurring revenue models and proven unit economics attract premium multiples from both domestic sponsors (MBK Partners, IMM PE, VIG Partners) and foreign PE (KKR Korea, Carlyle, Bain Capital Asia).

Consumer Brands

Korean consumer brands with proven APAC export traction — K-beauty, K-food, cultural content IP, gaming — command 7–10x EBITDA from strategic buyers. Domestic consumer brands with strong market positions but limited international distribution typically achieve 6–8x. Korean cultural export momentum has created genuine buyer urgency: Japanese, Chinese, Taiwanese, European, and US consumer groups compete for quality Korean brand assets.

Bain’s Asia-Pacific PE Report identifies consumer as one of the most competitive PE sectors in Korea. K-beauty platforms and multi-brand aggregators have attracted particular cross-border interest. Running chaebol affiliates (CJ, Lotte, AmorePacific subsidiaries), Japanese consumer groups, and financial sponsors simultaneously consistently produces better outcomes than bilateral negotiations.

Financial Services

Insurance broking, fintech infrastructure, wealth management platforms, and licensed investment advisory businesses sell at 5–9x EBITDA. Korea’s Financial Services Commission licensing creates meaningful barriers to entry — the regulatory cost of building a licensed business sustains acquisition premiums for quality incumbents. Foreign buyers include US and European asset managers entering Korea’s rapidly growing retail wealth market, and global fintech platforms seeking Korean payment infrastructure.

Education Technology

Korea’s education sector is complex after regulatory restrictions on hagwon (private tutoring academy) scale, but corporate learning platforms, professional certification businesses, and B2B education technology companies sell at 4–8x EBITDA. Businesses with enterprise contracts and offshore revenue diversification achieve higher multiples. Buyers include US and European corporate training platforms, global professional certification bodies, and domestic education conglomerates restructuring under the Value-Up Program.

Professional Services and Industrial

Consulting, HR outsourcing, accounting, staffing, and management services businesses sell at 4–7x EBITDA. Korea’s workforce restructuring is creating demand for HR and outsourcing services, particularly as chaebols reduce headcount in non-core divisions. Industrial manufacturing businesses — precision engineering, automotive components, electronics manufacturing services — also achieve 4–7x EBITDA, with premium valuations for assets with proven supply-chain relationships to Japanese, US, or European manufacturers.

South Korea’s Buyer Universe

Domestic Private Equity

Korea’s domestic PE market is one of Asia’s most sophisticated. MBK Partners, IMM Private Equity, Hahn & Company, Anchor Equity Partners, VIG Partners, and KPS Capital are all active mid-market buyers. Domestic PE brings speed, Korean-language due diligence capability, and familiarity with Korean business culture, reducing execution friction for domestic sellers. They are essential participants in any Korea sale process but should be competed against foreign sponsors and strategic buyers to maximise price tension.

Foreign Private Equity

KKR Korea, Bain Capital Asia, Carlyle, Blackstone, and CVC Capital maintain dedicated Korea deal teams. Foreign PE brings cross-border operational playbooks, access to international exit options (US/European public markets, secondary PE), and a higher willingness to pay for category-leading assets. Foreign PE has been particularly active in healthcare, technology, and consumer sectors where Korean assets have global relevance.

Chaebol Affiliates and Listed Strategics

Samsung affiliates, LG subsidiaries, SK Group, Hyundai, CJ Group, Lotte, and POSCO are all active acquirers in adjacent sectors. The Corporate Value-Up Program creates a dual dynamic: chaebols are simultaneously divesting non-core assets and acquiring in strategic growth areas. Chaebol buyers move at their own pace and apply internal return thresholds — they are essential participants to include in a competitive process but rarely the highest bidder when properly competed.

Japanese and Taiwanese Buyers

Japanese corporates are among Korea’s most consistent cross-border buyers in manufacturing, technology, and services, particularly where the Korean business has supply-chain integration with Japanese customers. Taiwanese buyers are active in electronics and precision manufacturing. Both buyer types move quickly for the right asset and are willing to pay strategic premiums for technology transfer and supply-chain control.

South Korea-Specific Sale Considerations

Corporate Value-Up Program and governance reform. The Korean government’s 2024 initiative directly affects the supply of carve-out assets. Sellers should understand whether their business is being divested under Value-Up pressure or represents an organic mid-market succession situation — buyers will price the distinction.

KFTC competition clearance. The Korea Fair Trade Commission requires post-merger notification when combined Korean revenues exceed ₩30B or a single party’s Korean revenues exceed ₩20B. Most mid-market transactions fall below these thresholds, but early assessment is worthwhile for any deal involving a domestic PE sponsor or strategic acquirer with existing Korean revenue.

Foreign investment review (FIPA). Foreign investment in Korean companies is generally open, but regulated sectors — banking, defence, energy, critical technology — require MOTIE or FSC approval. Advanced semiconductor assets may be subject to strategic review. Work with advisors experienced in FIPA classification when the target is in any regulated or potentially sensitive sector.

Capital gains tax. Approximately 25% total tax burden for individual shareholders on gains from share sales. Pre-sale reorganisation through treaty jurisdictions is a common mitigation strategy for owners with time to restructure. A Korea-specific tax opinion before beginning any process is essential.

Timeline. A structured South Korea sale typically runs 9–15 months from advisor appointment to closing. Korean deal culture rewards thorough preparation and respects parties who arrive with clean financials, management-ready operations, and well-documented investment thesis. Beginning preparation 6–9 months before target launch is advisable.

Improving Your Multiple Before Going to Market

1. Reduce founder dependence. Build a management team that can operate independently. This is the single most important multiple driver for succession-motivated Korea sales, where buyers discount visible founder dependency aggressively.
2. Clean up related-party transactions. Korean mid-market companies often have shareholder loans, intercompany arrangements, and cross-shareholdings that complicate buyer diligence. Rationalise these 12–18 months before going to market.
3. Prepare export documentation. International buyers pay premiums for Korean assets with documented export revenues, international customer references, and regulatory approvals in target buyer markets.
4. Access the full buyer universe. Korean sellers routinely underestimate the international buyer pool. Engage Korean PE, foreign sponsors, Japanese industrials, European healthcare strategics, and US technology buyers simultaneously for maximum competitive tension.
5. Prepare clean normalised financials. Three years of K-GAAP or IFRS audited statements, a normalised EBITDA schedule removing owner-discretionary costs, and clear revenue recognition reduce due diligence friction with all buyer types.
6. Obtain a tax opinion. Korea-specific CGT exposure, treaty qualification for likely buyer jurisdictions, and pre-sale reorganisation options should be assessed before beginning any process.

For the step-by-step sale process context, see Lyndon’s South Korea M&A market overview and our M&A advisor in Seoul page. For the full process from preparation to closing, see how to sell a business in South Korea.

Submit a confidential South Korea valuation inquiry →